Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children
© The Author(s) 2017
Received: 25 August 2017
Accepted: 19 December 2017
Published: 29 December 2017
Young children are at greatest risk for malaria-associated morbidity and mortality. The immune response of young children differs in fundamental ways from that of adults, and these differences likely contribute to the increased susceptibility of children to severe malaria and to their delayed development of immunity. Elevated levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute infection contribute to the control of parasitaemia, but are also responsible for much of the immunopathology seen during symptomatic disease. Clinical immunity to malaria may depend upon the ability to regulate these pro-inflammatory responses, possibly through mechanisms of immunologic tolerance. In order to explore the effect of age on the immune response to malaria and the development of clinical immunity, cytokines and chemokines were measured in the plasma of children at day 0 of an acute malaria episode and during convalescence.
Younger children presenting with acute malaria exhibited much higher levels of TNF, IL2, and IL6, as well as increased Th1 associated chemokines IP10, MIG, and MCP1, compared to older children with acute malaria. Additionally, the regulatory cytokines IL10 and TNFRI were dramatically elevated in younger children compared to older children during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened in later childhood.
Together these data suggest that there is a profound blunting of the cytokine and chemokine response to malaria among older children residing in endemic settings, which may be due to repeated malaria exposure, intrinsic age-based differences in the immune response, or both.
Plasmodium falciparum malaria is responsible for one in every five childhood deaths in Africa . The risk for severe disease and death is highest in early childhood, and declines with increasing age as clinical immunity develops after repeated exposures. Children living in malaria-endemic areas eventually develop clinical immunity to malaria, which protects against symptoms but not against infection. However, this immunity develops only after years of sustained exposure. The reasons for this delayed immunity are probably multifactorial. Antigenic diversity of the parasite likely plays a role, and this diversity comes in two forms: genetically stable allelic polymorphisms of antigen-coding genes, which vary between isolates, and antigenic switching by individual isolates, which alters antibody-binding sites of malarial proteins expressed on the surface of infected red blood cells . However, evidence also suggests that age-related differences in the developing immune system of children contribute to their slow development of immunity [3, 4].
Compared to adults, infant immune cells (including monocytes, dendritic cells and T cells) are biased toward the production of regulatory, Th2, and Th17 cytokines and exhibit lower production of proinflammatory Th1 cytokines [5–11]. As a result, infants are more susceptible than adults to numerous viral, bacterial, and protozoal pathogens, and generally exhibit delayed pathogen clearance compared to older children and adults. Hence, it is not surprising that the acquisition of anti-malarial immunity follows a different trajectory in young children than in adults, as has been described in several longitudinal studies of Javanese transmigrants [3, 4]. These studies suggest that adults are initially more susceptible to severe malaria than young children, but develop immunity to repeated infection much more rapidly.
During an acute malaria infection, cytokines and chemokines are elevated in peripheral blood and contribute to parasite clearance, but are also likely to be responsible for many of the symptoms and pathological changes seen during malaria disease. Experimental data indicate that the balance of pro and anti-inflammatory signals plays a large role in dictating the outcome of an infection, i.e. whether it leads to protection and/or immunopathology . Accordingly, clinical immunity might also depend upon the ability to moderate pro-inflammatory responses, as suggested by recent data from our group and others [13–15]. Indeed, malaria-naïve adults experimentally infected with P. falciparum can be divided into two prognostic groups based on their plasma cytokine profiles . The first group is characterized by a strong inflammatory response (defined as an eight to 82-fold increases in IFNγ above baseline, with similarly significant increases in TNF, IL12p70 and the chemokine MIG/CXCL9) and exhibits rapid parasite control but more severe symptoms. The second group is characterized by early TGFβ production and a weaker inflammatory response (less than a twofold increase in IFNγ above baseline), and exhibits weaker parasite control and fewer symptoms. Few data are available regarding cytokine levels in children, or in residents of endemic areas who are repeatedly exposed to malaria, and hence little is known regarding how plasma cytokines relate to outcomes of malaria infection in these settings. Mshana et al. observed an inverse relationship between age and plasma IFNγ and TNF in Gabonese children some years ago , but these results have yet to be extended to a more comprehensive view of the immune response. As children are the population most at risk for malaria-associated morbidity and mortality, it would be helpful to understand how age impacts cytokine and chemokine biomarkers of infection, and how childhood immune responses fit into to the paradigm put forward by studies of malaria in previously naïve adults.
Here, the cytokine response to malaria in younger (1–3 years) and older (7–10 years) children was compared. An array of 20 cytokines and chemokines were measured in plasma at the time of presentation with malaria, and again 3 weeks after treatment. The resulting data indicate that younger children, similar to naïve and partially immune adults, are more likely to mount a strong pro-inflammatory response to malaria, but that this response is tempered by large amounts of regulatory cytokine production. The response of older children was comparatively dampened, suggesting age-related differences in immunity and the development of partial clinical tolerance.
Written informed consent was obtained from the parent/guardian of all study participants. Study protocols were approved by the Uganda National Council of Science and Technology and the institutional review boards of the University of California, San Francisco, and Makerere University.
1–3 year olds
(n = 25)
7–9 year olds
(n = 23)
Malaria incidence in the preceding 365 days, median episodes ppy (IQR)
Malaria incidence in the following 365 days, median episodes ppy (IQR)
Parasite density at day 0, median parasites/μl (IQR)
Haemoglobin at day 0, median g/dl (IQR)
Thick blood smears were stained with 2% Giemsa for 30 min. Thick smears were evaluated for the presence of parasitaemia (asexual forms only) and gametocytes. Parasite densities were calculated by counting the number of asexual parasites per 200 leukocytes (or per 500, if the count was less than 10 parasites or gametocytes per 200 leukocytes), assuming a leukocyte count of 8000/μl. A smear was considered negative after reviewing 100 high-powered fields. For quality control, a second microscopist read all slides and a third reviewer was used to settle any discrepant readings. Haemoglobin concentration was assessed using a battery-operated portable haemoglobinometer (HemoCue Ltd., Angelholm, Sweden) and estimated to an accuracy of 1 g/dl.
6–10 ml of blood were obtained in acid citrate dextrose tubes. Plasma was collected by centrifugation and cryopreserved in − 80 freezers. Samples were shipped to San Francisco on dry ice prior to thaw and analysis.
The concentrations of 20 cytokines and chemokines were measured in plasma samples using Luminex technology (Luminex Corporation, Austin, TX, USA). Fourteen cytokines [TNF, TNFRI, IFNγ, IL1β, IL2, IL4, IL5, IL6, IL7, IL8, IL10, IL12p70, IL17, IL23] and six chemokines [MIG, MDC, MIP1α, MCP1, IP10, TARC] were analysed using a custom R&D Magnetic Luminex Screening Assay Human Premixed Multi-Analyte Kit (Catalog Number LXSAHM). Plasma was diluted 1:2 as per the manufacturers recommendations. All samples were analysed in duplicate. Protocols were performed as indicated by the vendor: Briefly, 50 μl of provided standard or test sample, along with 50 μl of the mixed microparticles, were added to each well of a 96-well micro-titer plate. After 2 h of incubation and washing at room temperature, 50 μl of diluted biotin antibody cocktail was added to each well. Samples were incubated for another hour. After washing, 50 μl of diluted Streptavidin-PE were added to each well. The plate was incubated for 30 min, washed, and the microparticles were resuspended in 100 μl of wash buffer. The plate was read on a Luminex MAGPIX CCD Imager and data were analysed using xPONENT software (v4.2). A minimum of 50 beads per region were analysed. A curve fit was applied to each standard curve according to the manufacturer’s instructions and sample concentrations were interpolated from the standard curves. MFIs were background subtracted. Variability between duplicates was minimal, with an average coefficient of variance of 5.2%. Age groups and time points were randomly distributed between plates to minimize batch effects. The limit of detection for each analyte was as follows: TNF: 14.83 pg/ml, TNFR1: 220.58 pg/ml, IFNγ: 7.55 pg/ml, IL1B: 17.75 pg/ml, IL2: 30.62 pg/ml, IL4: 18.26, IL5: 17.57 pg/ml, IL6: 14.03 pg/ml, IL7: 5.84, IL8: 8.13 pg/ml, IL10: 13.64 pg/ml, IL12p70: 278.45 pg/ml, IL17a: 21.42 pg/ml, IL23: 239.36, MIG: 396.06 pg/ml, MDC: 59.01 pg/ml, MIP1α: 60.39 pg/ml, MCP1: 32.70 pg/ml, IP10: 3.78 pg/ml, TARC: 9.06 pg/ml. Samples below the limit of detection were either given a value at the limit of detection, or half the limit of detection when log-transformed for statistical analysis.
Human IFNγ BD OptEIA ELISA II Kits (Catalog # 550612) were used to quantify IFNγ levels in plasma. Samples were diluted 1:2 and run in duplicate using the protocol provided by the manufacturer. Plates were read on a SpectraMax M2 (Molecular Devices) and analysed using SoftMax Pro (v) software to fit a curve to the standards supplied by the vendor. Background absorbance was subtracted from sample measurements. The limit of detection for this assay was interpolated from the standard curve to be 5 pg/ml.
All statistical analyses were performed using Prism 7.0a (GraphPad) or STATA SE version 13.1 (College Station). Comparisons of malaria between age groups, as well as comparisons of cytokine and chemokine concentrations between age groups and timepoints, were done using the Wilcoxon rank sum test or the Wilcoxon signed-rank test for paired data (i.e. day 0 vs. week 3). Associations between parasite densities and cytokine/chemokine concentrations were assessed using Spearman correlation. All multivariate statistics were derived by linear regression models with transformed variables following log or square root-transformation of any non-normal variables. Two-sided P values were calculated for all test statistics and P < 0.05 was considered significant.
Study design and clinical characteristics
Children who presented at the time of an acute malaria episode were enrolled to undergo an initial blood draw and a follow up draw 3 weeks after treatment. Subjects were recruited as part of a nested sub-study within an ongoing longitudinal cohort study of childhood malaria in Eastern Uganda. Details of this study have been published elsewhere . The study site is notable for its extremely high malaria transmission intensity, with an annual entomological inoculation rate of 310 infective bites per person year as measured in 2013. For children in this sub-study (n = 48), data regarding malaria incidence, parasite density, and haemoglobin at the time of blood sampling are shown in Table 1. Incident episodes of malaria were defined as all febrile episodes accompanied by any parasitaemia, but not preceded by another treatment in the prior 14 days. To minimize heterogeneity in plasma cytokine levels resulting from incident malaria, children were excluded if they arrived to the clinic more than 48 h after the onset of fever, had a parasite density less than 5000 parasites/μl, had received anti-malarial treatment any time in the prior month, or if there was any clinical suspicion of non-malarial intercurrent illness (e.g. upper respiratory symptoms or diarrhoea).
Parasite density was assessed by blood smears performed on-site. Subjects were removed from the study if convalescent samples tested positive for parasitaemia by blood smear at 3 weeks after treatment. As expected, the median parasite density at day 0 for children in the 1–3 year age group was significantly higher than for children in the 7–10 year age group (Table 1). Haemoglobin levels in the peripheral blood were lower in younger children than older children (Table 1), but were not associated with parasitaemia levels in either age group.
Pro-inflammatory cytokines are higher in young children with acute malaria
Relationships to age and parasite density
1–3 yr olds
7–9 yr olds
PD X AG
Regulatory cytokines including IL10 are markedly higher during acute malaria in young children
Because regulatory responses are important for limiting the pathology associated with malaria infection, we also quantified concentrations of IL10, sTNFRI, IL4, IL5, IL7, IL17 and IL23. As with the pro-inflammatory cytokine levels discussed above, levels of the regulatory cytokines IL10 and sTNFRI were markedly higher in young children compared to older children during acute malaria. IL10 levels were significantly higher in both age groups at day 0 as compared with convalescence (Fig. 1b). However, day 0 levels in the younger age group were tenfold higher than those of older children at this timepoint (mean of 609 pg/ml for ages 1–3; mean of 60 pg/ml for age 7–10). IL10 is produced by myeloid-derived cells and most lymphocyte subsets, and is thought to control immunopathology and symptoms by limiting cellular immune responses [14, 23].
The soluble TNF receptor TNFRI was also elevated at day 0 in both age groups, with significantly higher concentrations in the younger age group (Fig. 1b). sTNFRI plays a complex role in regulating extracellular TNF availability, with the capacity to stabilize bioactive TNF when it is present in low concentrations or, instead, neutralize TNF when the cytokine is present in excess . Little is known about the role of sTNFRI during malaria infection.
The Th2 cytokine IL4, while present at detectable levels in many children, showed no relationship with age or time after infection. IL17, IL23, IL5 and IL7 were undetectable in all samples.
Pro-inflammatory/regulatory ratios are higher in older children
Th1 plasma chemokines during acute malaria infection are elevated in younger children
Parasite density trended toward being a significant predictor for these chemokines in univariate analysis, but only age remained significant in multivariate analysis. There were no significant interactions between age and parasite density, and stratifying by age group to look at the influence of parasite density on chemokine concentrations did not reveal any further relationships. (Table 2). Thus, similar to pro-inflammatory cytokine production, younger children are more likely to respond with higher levels of the pro-inflammatory chemokines IP10, MIG and MCP1 during an acute malaria episode, regardless of parasite density at time of infection.
The Th2 chemokine CCL17 is elevated during convalescence, particularly among younger children
Plasma concentrations of chemokines known to bind CCR4, a receptor associated with Th2 CD4+ T cells, exhibited a different pattern from that described above for CXCR3-binding chemokines. These CCR4-binding chemokines include thymus activation regulated chemokine (TARC)/CCL17, human macrophage derived chemokine (MDC)/CCL22, and macrophage inflammatory protein (MIP1α). TARC concentrations were significantly elevated during convalescence as compared to day 0 in both younger and older children suffering an acute malaria episode (Fig. 5b).
MDC was elevated at both day 0 and week 3 in younger children as compared to the older age group; however, there were no significant differences between timepoints for either age group (Fig. 5b), though concentrations did trend upwards at week 3 in younger children. MIP1α showed no association with age group or time point. Additionally, there were no associations between parasite density and concentrations of these chemokines at any individual time point (Table 2). Thus, despite the Th2-skewing of infant immune cells, chemokines that may have a Th2 bias do not show a strong association with age or with parasite density during acute malaria.
This study sought to determine the effect of age on peripheral blood cytokine and chemokine levels during acute malaria infection in a highly endemic setting. The resulting data indicate that older children respond with diminished levels of the pro-inflammatory cytokines TNF, IL2 and IL6, as well as Th1-biased chemokines when compared to younger children at the same stage of infection. Moreover, older children had strikingly lower plasma concentrations of the regulatory cytokines IL10 and sTNFRI than younger children. Together these data suggest that there is a profound blunting of the cytokine response to malaria among older children residing in endemic settings, which may be due to repeated malaria exposure, to intrinsic age-based differences in the immune response, or to a combination of both factors.
These observations are consistent with the idea that repeated malaria may drive the host towards a disease tolerance state in order to reduce the negative impacts of infection-related pathology . While the exact nature of malaria-induced tolerance requires further investigation, several studies of both innate [29–31] and adaptive [32, 33] cell populations indicate that exhaustion and immunoregulatory pathways play a part. A recent study by Ademoule et al. found that pro-inflammatory cytokine responses during acute malaria, including TNF, IFNγ, IL1β, IL2, IL8, IL6, IL12 and GM-CSF, were decreased in areas with high transmission intensity, lending support to the idea that disease tolerance driven by sustained exposure is reflected by plasma cytokine concentration. Interestingly, TNF, IFNγ, IL6 and IL10 correlated with parasitaemia levels in low transmission areas but not high transmission areas in this study . This last observation is supported by an older study, in which Moncunill et al. found a correlation between IL6, IL10, and parasite density in previously naïve travellers and European migrants, but not semi-immune adults living in a malaria endemic area . There is also a line of evidence suggesting that disease tolerance may involve the generation of neutralizing antibodies to various malarial toxins, including hemozoin  and Glycosylphosphatidylinositol anchors , binding of which reduces the pyrogenic and cytokine-stimulating capacity of these compounds [36, 37] while leaving parasite replication unaffected. Murine models suggest that tolerance to malaria may in fact come at the price of impairing the host’s ability to limit parasite replication , and indeed, amongst human cohorts, asymptomatic infection among children does occur with significant parasitaemia in high transmission areas [26, 39–41]. Thus, dampened cytokine responses may serve to protect individuals from symptomatic disease while at the same time interfering with their ability to prevent re-infection.
Of note, the striking difference in malaria incidence between age groups following sampling, evident in Table 1, may directly reflect the active development of clinical immunity or disease tolerance in older children. Alternatively, this may be an artifact of our small cohort. Amongst the much larger number of children enrolled at this site in the parent study, asymptomatic parasitaemia becomes prevalent around the age of 5 , thus, enrollment of children suffering from clinical malaria at the later age of 7–10 may have selected individuals on the verge of developing immunity or tolerance.
The main limitation of this study is its inability to uncouple the influence of prior malaria exposure from that of biological age in this cohort of children. Differences in cytokine production may reflect either the fact that the younger children have sustained less prior exposure to malaria than older children, or instead, intrinsic age-related differences in immune function. Several prior studies support the notion that biological age profoundly influences the development of immunity to malaria. In an elegant study of Javanese transmigrant families emigrating together from an area of little to no malaria transmission to an area of high malaria transmission, adults were found to develop immunity to P. falciparum much more rapidly than children [3, 4]; however, infants and young children were much less likely than adults to develop severe malaria requiring medical evacuation . These clinical observations are consistent with the finding that young children mounted an exuberant anti-inflammatory IL10 response, which might limit the inflammatory pathology observed in adults during a first episode of malaria. The increased concentration of IL10 in younger children may reflect the observation that infant monocytes and dendritic cells have been shown to produce less IFNγ, IL12, IL18, and IFNα after stimulation with TLR ligands in vitro, and instead produce more IL10, IL17, IL6, and IL23 than equivalent adults cells [5–7]. This propensity for an enhanced regulatory response may delay the development of robust T cell memory and antibody formation in very young children. A better understanding of how infant immune cells respond differently to infectious pathogens will be crucially important for the development of effective vaccines for children living in endemic areas.
The complete lack of detectable IFNγ or IL12p70, both in younger and in older children, was somewhat surprising. These findings are at odds with some prior descriptions of plasma cytokines during acute infection [16, 20–22], though it is important to note that these studies examined subjects who were previously malaria-naïve or suffering from severe malaria. In subjects who are routinely exposed to malaria infection, the pro-inflammatory response may be diminished or quickly controlled by regulatory mechanisms. This effect may be particularly exaggerated in this study area, where transmission is especially intense. In fact, a recent study of Nigerian pre-school aged children failed to find detectable levels of IFNγ in plasma during acute infection as well . The idea that IFNγ and IL12p70 levels are diminished in frequently-exposed individuals is supported by Ademolue et al., described above, where plasma concentrations of both cytokines were reduced amongst individuals from high transmission areas , and by previous work studying malaria-naïve travellers, who exhibit a higher inflammatory response during their first malaria episode as compared with previously exposed and semi-immune individuals [20, 21]. The response of previously naïve individuals in these cohorts included higher plasma concentrations of IFNγ and IL12p70. Both IL2 and IFNγ plasma concentrations were inversely correlated with time since immigration for individuals that had relocated to Europe [20, 21]. Additionally, even in controlled human malaria infection of naive study subjects, a subset of those infected exhibited little to no increase in plasma IFNγ , indicating a predisposition towards tolerance (i.e. fewer symptoms but poor parasite control). We cannot completely exclude the possibility, however, that the commercial Luminex and ELISA kits used in this study may have a reduced sensitivity compared to those used in prior reports, and that this may contribute to the lack of detectable IFNγ and IL12p70.
This study had additional limitations, including the inability to record the exact timing of infection, although all samples were obtained within 48 h of the onset of symptoms. Thus, when comparing these data to cytokine concentrations measured during controlled human malaria infection, the timing of sample collection in the present study was less uniform and individual measurements more variable. Helminth co-infection has been shown to impact cytokine responses to P. falciparum infection, in some circumstances biasing the immune environment towards a Th2-driven response [43, 44]. As co-infection may be more common in school-aged children , this may have confounded our observed age-related differences. Finally, because nearly all children living in Nagongera sustain heavy exposure to P. falciparum-infected mosquitoes, the cytokine responses of children from high- and low-transmission settings could not be compared.
Together, these findings provide new evidence that despite age-related differences in immune responses, young children respond with a largely pro-inflammatory Th1-type cytokine and chemokine response, similar to naïve travellers; however, they also show increased levels of the regulatory cytokines IL10 and sTNFRI, which may limit their ability to develop robust immunity to subsequent malaria infections. This inflammatory response is dampened in older children, suggesting both differences in age-related immune function and the development of partial clinical tolerance.
LF and MEF conceived of and designed the study. MRK and GD led the parent study clinical trial. JR, PJ, AK, EA oversaw the study logistics and the collection of samples. LF and HV performed the experiments. MP participated in experimental design. LF performed data analysis. All authors participated in the writing of the manuscript. All authors read and approved the final manuscript.
We are tremendously grateful to the study participants and families who have graciously consented to the study. We would like to thank all of the study team members for their dedication and exceptional work.
The authors declare they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
Informed consent was obtained from the parent or guardian of all study participants. The study protocol was approved by the Uganda National Council of Science and Technology (UNCST), and the institutional review boards of the University of California, San Francisco (UCSF) and Makerere University.
Support for this work was provided by the National Institute of Health, National Institute of Allergy and Infectious Diseases 2R01AI093615-06 (MEF), NIH 5K24AI113002-03 (MEF), U19AI089674 (MEF and GD), as well as the National Center for Advancing Translational Sciences UL1 TR001872 (LF).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. World malaria report 2016. Geneva: World Health Organization; 2016.Google Scholar
- Ferreira MU, da Silva Nunes M, Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol. 2004;11:987–95.PubMedPubMed CentralGoogle Scholar
- Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today. 1995;11:105–11.View ArticlePubMedGoogle Scholar
- Baird JK, Jones TR, Danudirgo EW, Annis BA, Bangs MJ, Basri H, et al. Age-dependent acquired protection against Plasmodium falciparum in people having 2 years exposure to hyperendemic malaria. Am J Trop Med Hyg. 1991;45:65–76.View ArticlePubMedGoogle Scholar
- Goriely S, Van Lint C, Dadkhah R, Libin M, De Wit D, Demonté D, et al. A defect in nucleosome remodeling prevents IL-12 (p35) gene transcription in neonatal dendritic cells. J Exp Med. 2004;199:1011–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun. 2002;70:6688–96.View ArticlePubMedPubMed CentralGoogle Scholar
- Dadaglio G, Sun C-M, Lo-Man R, Siegrist CA, Leclerc C. Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells. J Immunol. 2002;168:2219–24.View ArticlePubMedGoogle Scholar
- Webster RB, Rodriguez Y, Klimecki WT, Vercelli D. The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture. J Biol Chem. 2007;282:700–9.View ArticlePubMedGoogle Scholar
- White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol. 2002;168:2820–7.View ArticlePubMedGoogle Scholar
- Kaminuma O, Kitamura F, Miyatake S, Yamaoka K, Miyoshi H, Inokuma S, et al. T-box 21 transcription factor is responsible for distorted T(H)2 differentiation in human peripheral CD4+ T cells. J Allergy Clin Immunol. 2009;123(813–23):e3.Google Scholar
- Black A, Bhaumik S, Kirkman RL, Weaver CT, Randolph DA. Developmental regulation of Th17-cell capacity in human neonates. Eur J Immunol. 2012;42:311–9.View ArticlePubMedGoogle Scholar
- Rovira-Vallbona E, Moncunill G, Bassat Q, Aguilar R, Machevo S, Puyol L, et al. Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Malar J. 2012;11:181.View ArticlePubMedPubMed CentralGoogle Scholar
- Jagannathan P, Kim CC, Greenhouse B, Nankya F, Bowen K, Eccles-James I, et al. Loss and dysfunction of Vδ2+ γδ T cells are associated with clinical tolerance to malaria. Sci Transl Med. 2014;6:251ra117.View ArticlePubMedPubMed CentralGoogle Scholar
- Portugal S, Moebius J, Skinner J, Doumbo S, Doumtabe D, Kone Y, et al. Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog. 2014;10:e1004079.View ArticlePubMedPubMed CentralGoogle Scholar
- Tran TM, Jones MB, Ongoiba A, Bijker EM, Schats R, Venepally P, et al. Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria. Sci Rep. 2016;6:31291.View ArticlePubMedPubMed CentralGoogle Scholar
- Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, King E, et al. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol. 2006;177:5736–45.View ArticlePubMedGoogle Scholar
- Mshana RN, Boulandi J, Mshana NM, Mayombo J, Mendome G. Cytokines in the pathogenesis of malaria: levels of IL-I beta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol. 1991;34:131–9.PubMedGoogle Scholar
- Kamya MR, Arinaitwe E, Wanzira H, Katureebe A, Barusya C, Kigozi SP, et al. Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control. Am J Trop Med Hyg. 2015;92:903–12.View ArticlePubMedPubMed CentralGoogle Scholar
- Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun. 2000;68:3909–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Moncunill G, Mayor A, Jiménez A, Nhabomba A, Puyol L, Manaca MN, et al. Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure. PLoS ONE. 2013;8:e55756.View ArticlePubMedPubMed CentralGoogle Scholar
- Moncunill G, Mayor A, Bardají A, Puyol L, Nhabomba A, Barrios D, et al. Cytokine profiling in immigrants with clinical malaria after extended periods of interrupted exposure to Plasmodium falciparum. PLoS ONE. 2013;8:e73360.View ArticlePubMedPubMed CentralGoogle Scholar
- Robinson LJ, D’Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS, et al. Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun. 2009;77:3033–43.View ArticlePubMedPubMed CentralGoogle Scholar
- Butler NS, Harris TH, Blader IJ. Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions? Trends Parasitol. 2013;29:593–602.View ArticlePubMedGoogle Scholar
- Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996;7:231–40.View ArticlePubMedGoogle Scholar
- Noone C, Parkinson M, Dowling DJ, Aldridge A, Kirwan P, Molloy SF, et al. Plasma cytokines, chemokines and cellular immune responses in pre-school Nigerian children infected with Plasmodium falciparum. Malar J. 2013;12:5.View ArticlePubMedPubMed CentralGoogle Scholar
- Ademolue TW, Aniweh Y, Kusi KA, Awandare GA. Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity. Malar J. 2017;16:145.View ArticlePubMedPubMed CentralGoogle Scholar
- Ioannidis LJ, Nie CQ, Hansen DS. The role of chemokines in severe malaria: more than meets the eye. Parasitology. 2014;141:602–13.View ArticlePubMedGoogle Scholar
- Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012;335:936–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG, et al. Trained immunity. A program of innate immune memory in health and disease. Science. 2016;352:aaf1098.View ArticlePubMedPubMed CentralGoogle Scholar
- Saeed S, Quintin J, Kerstens HHD, Rao NA, Aghajanirefah A, Matarese F, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014;345:1251086.View ArticlePubMedPubMed CentralGoogle Scholar
- Boutlis CS, Yeo TW, Anstey NM. Malaria tolerance–for whom the cell tolls? Trends Parasitol. 2006;22:371–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Wykes MN, Horne-Debets JM, Leow C-Y, Karunarathne DS. Malaria drives T cells to exhaustion. Front Microbiol. 2014;5:249.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh NJ, Schwartz RH. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J Exp Med. 2003;198:1107–17.View ArticlePubMedPubMed CentralGoogle Scholar
- Biswas S, Karmarkar MG, Sharma YD. Antibodies detected against Plasmodium falciparum haemozoin with inhibitory properties to cytokine production. FEMS Microbiol Lett. 2001;194:175–9.View ArticlePubMedGoogle Scholar
- Boutlis CS, Gowda DC, Naik RS, Maguire GP, Mgone CS, Bockarie MJ, et al. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infect Immun. 2002;70:5052–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Bate CA, Taverne J, Bootsma HJ, Mason RC, Skalko N, Gregoriadis G, et al. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology. 1992;76:35–41.PubMedPubMed CentralGoogle Scholar
- Bate CA, Kwiatkowski D. Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria. Infect Immun. 1994;62:3086–91.PubMedPubMed CentralGoogle Scholar
- Råberg L, Sim D, Read AF. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science. 2007;318:812–4.View ArticlePubMedGoogle Scholar
- Gonçalves BP, Huang C-Y, Morrison R, Holte S, Kabyemela E, Prevots DR, et al. Parasite burden and severity of malaria in Tanzanian children. N Engl J Med. 2014;370:1799–808.View ArticlePubMedPubMed CentralGoogle Scholar
- Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA. 2005;293:1461–70.View ArticlePubMedGoogle Scholar
- Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Rek J, Katrak S, Obasi H, Nayebare P, Katureebe A, Kakande E, et al. Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda. Malar J. 2016;15:470.View ArticlePubMedPubMed CentralGoogle Scholar
- Diallo TO, Remoue F, Schacht AM, Charrier N, Dompnier J-P, Pillet S, et al. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol. 2004;26:365–9.View ArticlePubMedGoogle Scholar
- Ateba-Ngoa U, Adegnika AA, Zinsou JF, Kassa Kassa RF, Smits H, Massinga-Loembe M, et al. Cytokine and chemokine profile of the innate and adaptive immune response of Schistosoma haematobium and Plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné, Gabon. Malar J. 2015;14:94.View ArticlePubMedPubMed CentralGoogle Scholar
- Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, et al. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg. 2007;77:88–98.PubMedPubMed CentralGoogle Scholar
- Farrington L, Vance H, Rek J, Prahl P, Jagannathan P, Katureebe A, Arinaitwe E, Kamya MR, Dorsey G, Feeney M. Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children data sets. Figshare, 2017. http://0-dx.doi.org.brum.beds.ac.uk/10.6084/m9.figshare.5518825.